Whitepapers , Drug Product , Pediatrics

Global Approaches to Oral Drug Administration Using Enteral Feeding Tubes: A Review of FDA and EMA Guidance

3 April 2026
Overview

Enteral feeding tubes (EFTs) are essential to use in cases where patients are unable to swallow pills, tablets, or other oral dosage forms. This may be due to conditions such as dysphagia, neurological disorders, or critical illness. While this practice is common, it introduces significant formulation challenges that impact safety, efficacy, and outcomes in both adult and children patient populations.

 In this article, we look at factors involved in properly administering drug products through EFTs, including factors such as:

  • Chemical compatibility and integrity
  • Interaction with enteral feeding tube materials
  • Physical stability and enteral feeding tube patency
  • Labelling and instructions for use

You can also read more from our experts on this topic in the Summer 2026 issue of International Pharmaceutical Industry (IPI).

Download
Date
3 April 2026
Ask The Experts

Drug product formulation questions? Get answers from our team.

Have a question about your drug product formulation? Ask a member of our team about our capabilities for formulation development, solubility enhancement, and more.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Dr. Asma Patel

VP, Global Commercial and Scientific Consulting - Drug Product

Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...

About Asma
John McDermott

VP, Scientific Consulting

John McDermott leads Quotient Sciences' global drug development consulting, research fellows, modeling & simulation, and clien...

About John
Dr. Helen Baker

Director, Formulation Design, Analytical Development

Dr. Helen Baker has over 15 years of formulation and product development experience within the pharmaceutical, biotech, and agrono...

About Helen
Let's Talk
Humanity can't wait, so neither can we. Discuss your drug program today.